Disclosed are methods for downmodulating an immune response comprising contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1) to thereby modulate the immune response.

 
Web www.patentalert.com

< Aza-peptide macrocyclic hepatitis C serine protease inhibitors

< Energy-beam-curable thermal-releasable pressure-sensitive adhesive sheet and method for producing cut pieces using the same

> Delivery of immunogenic molecules vis HBsAg particles

> Use of polyamine analogs for amyotrophic lateral sclerosis

~ 00255